NSG 533 Final Exam V3 | NSG 533
Advanced Pharmacology | Wilkes
University | 2026 Q&A with Rationale
(Wilkes NSG533 Final Exam 2026)
1. A patient with a history of heart failure is prescribed an ACE inhibitor. Which physiological
effect should the clinician anticipate as a direct result of this medication?
A. Reduced secretion of aldosterone
B. Increased peripheral vascular resistance
C. Stimulation of the sympathetic nervous system
D. Decreased levels of circulating bradykinin
Answer: A
Rationale: ACE inhibitors block the conversion of Angiotensin I to Angiotensin II, which
subsequently leads to a reduction in aldosterone secretion. This mechanism helps to
decrease sodium and water retention, thereby reducing preload and afterload in heart
failure patients. Clinicians must monitor for hyperkalemia since aldosterone normally
promotes potassium excretion.
2. Which pharmacodynamic concept describes the maximal effect that a drug can produce
regardless of the dose administered?
A. Potency
,B. Therapeutic Index
C. Affinity
D. Efficacy
Answer: D
Rationale: Efficacy refers to the maximum response achievable from a drug, reflecting its
intrinsic activity. While potency relates to the amount of drug needed to produce an effect,
efficacy is more clinically significant when comparing drugs with different maximum
ceilings. A drug with high efficacy is preferred in scenarios where a robust physiological
response is required.
3. When prescribing Metformin for Type 2 Diabetes, which laboratory value is the most
critical to assess prior to initiation?
A. Aspartate aminotransferase (AST)
B. Estimated Glomerular Filtration Rate (eGFR)
C. Serum Albumin
D. Thyroid Stimulating Hormone (TSH)
Answer: B
Rationale: Metformin is primarily excreted unchanged by the kidneys and can accumulate
in patients with renal impairment, increasing the risk of lactic acidosis. Current guidelines
, recommend avoiding initiation if the eGFR is below 30 mL/min/1.73m2. Regular
monitoring of renal function is mandatory throughout the duration of therapy.
4. A patient is taking Warfarin for atrial fibrillation and is now prescribed a broad-spectrum
antibiotic. What is the most likely pharmacological interaction?
A. Increased INR due to reduction of Vitamin K-producing gut flora
B. Decreased INR due to induction of CYP450 enzymes
C. Reduced antibiotic efficacy due to protein binding competition
D. Increased risk of thromboembolism due to Warfarin inhibition
Answer: A
Rationale: Broad-spectrum antibiotics can deplete the intestinal bacteria that synthesize
Vitamin K, which is the cofactor Warfarin antagonizes. This leads to an enhanced
anticoagulant effect and an elevation in the International Normalized Ratio (INR).
Clinicians should monitor the INR closely and consider a preemptive dose reduction of
Warfarin during antibiotic therapy.
5. Which of the following describes the mechanism of action of Tiotropium (Spiriva) in the
management of COPD?
A. Activation of Beta-2 adrenergic receptors
B. Antagonism of muscarinic M3 receptors
C. Inhibition of phosphodiesterase-4
Advanced Pharmacology | Wilkes
University | 2026 Q&A with Rationale
(Wilkes NSG533 Final Exam 2026)
1. A patient with a history of heart failure is prescribed an ACE inhibitor. Which physiological
effect should the clinician anticipate as a direct result of this medication?
A. Reduced secretion of aldosterone
B. Increased peripheral vascular resistance
C. Stimulation of the sympathetic nervous system
D. Decreased levels of circulating bradykinin
Answer: A
Rationale: ACE inhibitors block the conversion of Angiotensin I to Angiotensin II, which
subsequently leads to a reduction in aldosterone secretion. This mechanism helps to
decrease sodium and water retention, thereby reducing preload and afterload in heart
failure patients. Clinicians must monitor for hyperkalemia since aldosterone normally
promotes potassium excretion.
2. Which pharmacodynamic concept describes the maximal effect that a drug can produce
regardless of the dose administered?
A. Potency
,B. Therapeutic Index
C. Affinity
D. Efficacy
Answer: D
Rationale: Efficacy refers to the maximum response achievable from a drug, reflecting its
intrinsic activity. While potency relates to the amount of drug needed to produce an effect,
efficacy is more clinically significant when comparing drugs with different maximum
ceilings. A drug with high efficacy is preferred in scenarios where a robust physiological
response is required.
3. When prescribing Metformin for Type 2 Diabetes, which laboratory value is the most
critical to assess prior to initiation?
A. Aspartate aminotransferase (AST)
B. Estimated Glomerular Filtration Rate (eGFR)
C. Serum Albumin
D. Thyroid Stimulating Hormone (TSH)
Answer: B
Rationale: Metformin is primarily excreted unchanged by the kidneys and can accumulate
in patients with renal impairment, increasing the risk of lactic acidosis. Current guidelines
, recommend avoiding initiation if the eGFR is below 30 mL/min/1.73m2. Regular
monitoring of renal function is mandatory throughout the duration of therapy.
4. A patient is taking Warfarin for atrial fibrillation and is now prescribed a broad-spectrum
antibiotic. What is the most likely pharmacological interaction?
A. Increased INR due to reduction of Vitamin K-producing gut flora
B. Decreased INR due to induction of CYP450 enzymes
C. Reduced antibiotic efficacy due to protein binding competition
D. Increased risk of thromboembolism due to Warfarin inhibition
Answer: A
Rationale: Broad-spectrum antibiotics can deplete the intestinal bacteria that synthesize
Vitamin K, which is the cofactor Warfarin antagonizes. This leads to an enhanced
anticoagulant effect and an elevation in the International Normalized Ratio (INR).
Clinicians should monitor the INR closely and consider a preemptive dose reduction of
Warfarin during antibiotic therapy.
5. Which of the following describes the mechanism of action of Tiotropium (Spiriva) in the
management of COPD?
A. Activation of Beta-2 adrenergic receptors
B. Antagonism of muscarinic M3 receptors
C. Inhibition of phosphodiesterase-4
